Judy Schoeman, Ilde-Marié Kellerman, Paul C Rogers, Elena J Ladas, Carl J Lombard, Ronelle Uys, Mariana Kruger
{"title":"南非两个儿科肿瘤科癌症诊断中维生素和铁缺乏的患病率。","authors":"Judy Schoeman, Ilde-Marié Kellerman, Paul C Rogers, Elena J Ladas, Carl J Lombard, Ronelle Uys, Mariana Kruger","doi":"10.1080/08880018.2023.2188920","DOIUrl":null,"url":null,"abstract":"<p><p>This study investigates the prevalence of vitamin and iron deficiencies at cancer diagnosis. Newly diagnosed children between October 2018 and December 2020 at two South African pediatric oncology units (POUs) were assessed for nutritional and micronutrient status (Vit A, Vit B12, Vit D, folate, and iron). A structured interview with caregivers provided information regarding hunger and poverty risks. There were 261 patients enrolled with a median age of 5.5 years and a male-to-female ratio of 1:0.8. Nearly half had iron deficiency (47.6%), while a third had either Vit A (30.6%), Vit D (32.6%), or folate (29.7%) deficiencies. Significant associations existed between moderate acute malnutrition (MAM) and low levels of Vit A (48.4%; <i>p</i> = .005), Vit B12 (29.6%; <i>p</i> < .001), and folate (47.3%; <i>p</i> = .003), while Vit D deficiency was associated with wasting (63.6%) (<i>p</i> < .001). Males had significantly lower Vit D levels (respectively, 40.9%; <i>p</i> = .004). Folate deficiency was significantly associated with patients born at full term (33.5%; <i>p</i> = .017), age older than five years (39.8%; <i>p</i> = .002), residing in provinces Mpumalanga (40.9%) and Gauteng (31.5%) (<i>P</i> = .032); as well as having food insecurity (46.3%; <i>p</i> < .001), or hematological malignancies (41.3%; <i>p</i> = .004). This study documents the high prevalence of Vit A, Vit D, Vit B12, folate, and iron deficiency in South African pediatric cancer patients, demonstrating the need to include micronutrient assessment at diagnosis to ensure optimal nutritional support for macro-and micronutrients.</p>","PeriodicalId":19746,"journal":{"name":"Pediatric Hematology and Oncology","volume":" ","pages":"752-765"},"PeriodicalIF":1.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of vitamin and iron deficiencies at cancer diagnosis at two pediatric oncology units in South Africa.\",\"authors\":\"Judy Schoeman, Ilde-Marié Kellerman, Paul C Rogers, Elena J Ladas, Carl J Lombard, Ronelle Uys, Mariana Kruger\",\"doi\":\"10.1080/08880018.2023.2188920\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study investigates the prevalence of vitamin and iron deficiencies at cancer diagnosis. Newly diagnosed children between October 2018 and December 2020 at two South African pediatric oncology units (POUs) were assessed for nutritional and micronutrient status (Vit A, Vit B12, Vit D, folate, and iron). A structured interview with caregivers provided information regarding hunger and poverty risks. There were 261 patients enrolled with a median age of 5.5 years and a male-to-female ratio of 1:0.8. Nearly half had iron deficiency (47.6%), while a third had either Vit A (30.6%), Vit D (32.6%), or folate (29.7%) deficiencies. Significant associations existed between moderate acute malnutrition (MAM) and low levels of Vit A (48.4%; <i>p</i> = .005), Vit B12 (29.6%; <i>p</i> < .001), and folate (47.3%; <i>p</i> = .003), while Vit D deficiency was associated with wasting (63.6%) (<i>p</i> < .001). Males had significantly lower Vit D levels (respectively, 40.9%; <i>p</i> = .004). Folate deficiency was significantly associated with patients born at full term (33.5%; <i>p</i> = .017), age older than five years (39.8%; <i>p</i> = .002), residing in provinces Mpumalanga (40.9%) and Gauteng (31.5%) (<i>P</i> = .032); as well as having food insecurity (46.3%; <i>p</i> < .001), or hematological malignancies (41.3%; <i>p</i> = .004). This study documents the high prevalence of Vit A, Vit D, Vit B12, folate, and iron deficiency in South African pediatric cancer patients, demonstrating the need to include micronutrient assessment at diagnosis to ensure optimal nutritional support for macro-and micronutrients.</p>\",\"PeriodicalId\":19746,\"journal\":{\"name\":\"Pediatric Hematology and Oncology\",\"volume\":\" \",\"pages\":\"752-765\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Hematology and Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/08880018.2023.2188920\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/3/20 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Hematology and Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08880018.2023.2188920","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/3/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
本研究调查了维生素和铁缺乏在癌症诊断中的患病率。2018年10月至2020年12月期间,在南非两个儿科肿瘤科(POU)对新诊断的儿童进行了营养和微量营养素状况(维生素A、维生素B12、维生素D、叶酸和铁)评估。对照顾者的结构化访谈提供了有关饥饿和贫困风险的信息。共有261名患者入选,中位年龄为5.5岁 年,男女比例为1:0.8。近一半的人缺铁(47.6%),三分之一的人维生素a(30.6%)、维生素D(32.6%)或叶酸(29.7%)缺乏。中度急性营养不良(MAM)与低水平维生素A之间存在显著相关性(48.4%;p = .005)、维生素B12(29.6%;p p = .003),而维生素D缺乏与消瘦有关(63.6%)(p p = .004)。叶酸缺乏症与足月出生的患者显著相关(33.5%;p = .017),年龄在5岁以上(39.8%;p = .002),居住在普马兰加省(40.9%)和豪登省(31.5%)(P = .032);以及粮食不安全(46.3%;p p = .004)。这项研究记录了南非癌症儿科患者中维生素A、维生素D、维生素B12、叶酸和铁缺乏的高患病率,表明需要在诊断时纳入微量营养素评估,以确保对宏量和微量营养素的最佳营养支持。
Prevalence of vitamin and iron deficiencies at cancer diagnosis at two pediatric oncology units in South Africa.
This study investigates the prevalence of vitamin and iron deficiencies at cancer diagnosis. Newly diagnosed children between October 2018 and December 2020 at two South African pediatric oncology units (POUs) were assessed for nutritional and micronutrient status (Vit A, Vit B12, Vit D, folate, and iron). A structured interview with caregivers provided information regarding hunger and poverty risks. There were 261 patients enrolled with a median age of 5.5 years and a male-to-female ratio of 1:0.8. Nearly half had iron deficiency (47.6%), while a third had either Vit A (30.6%), Vit D (32.6%), or folate (29.7%) deficiencies. Significant associations existed between moderate acute malnutrition (MAM) and low levels of Vit A (48.4%; p = .005), Vit B12 (29.6%; p < .001), and folate (47.3%; p = .003), while Vit D deficiency was associated with wasting (63.6%) (p < .001). Males had significantly lower Vit D levels (respectively, 40.9%; p = .004). Folate deficiency was significantly associated with patients born at full term (33.5%; p = .017), age older than five years (39.8%; p = .002), residing in provinces Mpumalanga (40.9%) and Gauteng (31.5%) (P = .032); as well as having food insecurity (46.3%; p < .001), or hematological malignancies (41.3%; p = .004). This study documents the high prevalence of Vit A, Vit D, Vit B12, folate, and iron deficiency in South African pediatric cancer patients, demonstrating the need to include micronutrient assessment at diagnosis to ensure optimal nutritional support for macro-and micronutrients.
期刊介绍:
PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.